Similarly, chemokines such as CXCL-13 (C-X-C motif chemokine 13) as well as Fetuin A and glial fibrillary acidic protein seem elevated in CSF of MS patient as well, suggesting these molecules as potential biomarkers for disease activity and/or progression [23]. This evidence concerns the gene CXCL13 and myeloid sarcoma.